メディシノバ・インクの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/11/15 | 1,085 | 1,145 | 1,082 | 1,137 | ±0 | ±0% | 139,900 |
| 2018/11/14 | 1,158 | 1,180 | 1,131 | 1,137 | +8 | +0.7% | 156,400 |
| 2018/11/13 | 1,051 | 1,175 | 1,051 | 1,129 | +28 | +2.5% | 274,500 |
| 2018/11/12 | 1,153 | 1,169 | 1,097 | 1,101 | -96 | -8% | 344,100 |
| 2018/11/09 | 1,210 | 1,233 | 1,180 | 1,197 | -50 | -4% | 359,500 |
| 2018/11/08 | 1,350 | 1,355 | 1,235 | 1,247 | -86 | -6.5% | 601,700 |
| 2018/11/07 | 1,315 | 1,377 | 1,309 | 1,333 | +34 | +2.6% | 371,500 |
| 2018/11/06 | 1,210 | 1,300 | 1,210 | 1,299 | +93 | +7.7% | 247,600 |
| 2018/11/05 | 1,198 | 1,235 | 1,196 | 1,206 | +9 | +0.8% | 115,100 |
| 2018/11/02 | 1,205 | 1,221 | 1,180 | 1,197 | +12 | +1% | 188,400 |
| 2018/11/01 | 1,100 | 1,224 | 1,073 | 1,185 | +85 | +7.7% | 167,500 |
| 2018/10/31 | 1,079 | 1,115 | 1,061 | 1,100 | +64 | +6.2% | 200,600 |
| 2018/10/30 | 990 | 1,068 | 983 | 1,036 | +11 | +1.1% | 230,400 |
| 2018/10/29 | 1,050 | 1,070 | 1,005 | 1,025 | -16 | -1.5% | 142,600 |
| 2018/10/26 | 1,050 | 1,068 | 991 | 1,041 | +23 | +2.3% | 249,500 |
| 2018/10/25 | 1,049 | 1,085 | 1,009 | 1,018 | -151 | -12.9% | 504,600 |
| 2018/10/24 | 1,145 | 1,173 | 1,102 | 1,169 | +29 | +2.5% | 225,900 |
| 2018/10/23 | 1,185 | 1,205 | 1,139 | 1,140 | -54 | -4.5% | 205,800 |
| 2018/10/22 | 1,181 | 1,206 | 1,155 | 1,194 | -18 | -1.5% | 238,500 |
| 2018/10/19 | 1,218 | 1,223 | 1,182 | 1,212 | -38 | -3% | 253,300 |
| 2018/10/18 | 1,284 | 1,284 | 1,248 | 1,250 | -28 | -2.2% | 106,300 |
| 2018/10/17 | 1,309 | 1,309 | 1,278 | 1,278 | -1 | -0.1% | 114,900 |
| 2018/10/16 | 1,290 | 1,295 | 1,265 | 1,279 | -3 | -0.2% | 78,200 |
| 2018/10/15 | 1,273 | 1,300 | 1,240 | 1,282 | +12 | +0.9% | 153,100 |
| 2018/10/12 | 1,184 | 1,286 | 1,183 | 1,270 | +58 | +4.8% | 192,900 |
| 2018/10/11 | 1,196 | 1,245 | 1,150 | 1,212 | -95 | -7.3% | 517,200 |
| 2018/10/10 | 1,355 | 1,392 | 1,296 | 1,307 | -70 | -5.1% | 338,100 |
| 2018/10/09 | 1,373 | 1,404 | 1,354 | 1,377 | -51 | -3.6% | 239,300 |
| 2018/10/05 | 1,382 | 1,471 | 1,368 | 1,428 | +34 | +2.4% | 400,400 |
| 2018/10/04 | 1,400 | 1,418 | 1,388 | 1,394 | -8 | -0.6% | 123,400 |
| 2018/10/03 | 1,410 | 1,420 | 1,368 | 1,402 | -40 | -2.8% | 240,900 |
| 2018/10/02 | 1,470 | 1,478 | 1,418 | 1,442 | -35 | -2.4% | 323,300 |
| 2018/10/01 | 1,437 | 1,477 | 1,426 | 1,477 | +75 | +5.3% | 562,100 |
| 2018/09/28 | 1,380 | 1,420 | 1,379 | 1,402 | +37 | +2.7% | 293,900 |
| 2018/09/27 | 1,388 | 1,398 | 1,362 | 1,365 | -29 | -2.1% | 240,500 |
| 2018/09/26 | 1,382 | 1,450 | 1,360 | 1,394 | +85 | +6.5% | 698,600 |
| 2018/09/25 | 1,300 | 1,311 | 1,287 | 1,309 | -14 | -1.1% | 151,800 |
| 2018/09/21 | 1,349 | 1,358 | 1,302 | 1,323 | +3 | +0.2% | 210,700 |
| 2018/09/20 | 1,256 | 1,388 | 1,251 | 1,320 | +87 | +7.1% | 493,500 |
| 2018/09/19 | 1,248 | 1,250 | 1,224 | 1,233 | -27 | -2.1% | 116,900 |
| 2018/09/18 | 1,275 | 1,279 | 1,250 | 1,260 | -16 | -1.3% | 90,400 |
| 2018/09/14 | 1,280 | 1,304 | 1,268 | 1,276 | -12 | -0.9% | 86,000 |
| 2018/09/13 | 1,230 | 1,291 | 1,225 | 1,288 | +44 | +3.5% | 97,800 |
| 2018/09/12 | 1,266 | 1,277 | 1,213 | 1,244 | -36 | -2.8% | 177,900 |
| 2018/09/11 | 1,305 | 1,310 | 1,280 | 1,280 | -33 | -2.5% | 140,100 |
| 2018/09/10 | 1,300 | 1,328 | 1,268 | 1,313 | +28 | +2.2% | 144,900 |
| 2018/09/07 | 1,230 | 1,290 | 1,216 | 1,285 | +28 | +2.2% | 181,200 |
| 2018/09/06 | 1,266 | 1,280 | 1,196 | 1,257 | -56 | -4.3% | 439,200 |
| 2018/09/05 | 1,395 | 1,404 | 1,288 | 1,313 | -92 | -6.5% | 478,100 |
| 2018/09/04 | 1,382 | 1,420 | 1,374 | 1,405 | +10 | +0.7% | 294,500 |
1651～
1700
件表示中 / 3769件
類似銘柄と比較する
現在ご覧いただいている「メディシノバ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| メディシノバ | 19,700円 | - | - | - | - | - |
|
- |
| ソレイジア | 3,900円 | +311.4% | - | 0.00% | - | 7.82倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
| カイオム | 14,200円 | +2.6% | - | 0.00% | - | 6.40倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
| 坪田ラボ | 37,200円 | +3.2% | -21.7% | 0.00% | 63.92倍 | 6.05倍 |
|
近視進行抑制、脳活性化などに強いバイオベンチャー。企業との早期契約による収益化で実績 |
| 仁 丹 | 222,600円 | +0.3% | +9.2% | 2.92% | 12.67倍 | 0.75倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
市場注目の銘柄
チャート関連のコラム
